Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Xia You"'
Publikováno v:
Pifu-xingbing zhenliaoxue zazhi, Vol 30, Iss 1, Pp 21-25 (2023)
Objective To provide the evidence base for the safety of biologics in the treatment of psoriasis, we retrospectively analyzed tuberculosis (TB) infection and its activation in psoriatic patients treated with biologics. Methods Information of 2 704 ps
Externí odkaz:
https://doaj.org/article/3dcbeb8e93a9454da8eaa95eb83923d9
Autor:
Xiaoxiao CHEN, Xin LI, Xiaojiao ZHAO, Xia YOU, Jian LONG, Ping HE, Jia YUAN, Zhaogui LIU, Shuang LI, Yi LEI, Xiyang DONG, Quan ZHOU, Jianjian ZHU
Publikováno v:
Pifu-xingbing zhenliaoxue zazhi, Vol 29, Iss 5, Pp 421-428 (2022)
Objective To reveal the association between different types of panniculitis and tuberculosis infection. Methods The clinical data of 33 patients with panniculitis were collected from January 2019 to December 2021 and analyzed association of epidemiol
Externí odkaz:
https://doaj.org/article/90b0d9af771141a88b4593484d92904f
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionSarcomas are classified into two types, bone sarcoma and soft tissue sarcoma (STS), which account for approximately 1% of adult solid malignancies and 20% of pediatric solid malignancies. There exist more than 50 subtypes within the two t
Externí odkaz:
https://doaj.org/article/2623aa890a5d448cb872e3df1890022a
Case report: Unique FLT4 variants associated with differential response to anlotinib in angiosarcoma
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Angiosarcoma (AS) is a rare, clinically aggressive tumor with limited treatment options and a poor prognosis. Mutations involving the angiogenesis-related genesTP53, PTPRB, PLCG1, KDR as well as FLT4 amplification have been observed in AS. There is a
Externí odkaz:
https://doaj.org/article/ab9211e38f154505ba1a0f2f4c10a0ae
Autor:
Zulin Wu, Haiqian Xu, Pei Wang, Ling Liu, Juan Cai, Yun Chen, Xiaomin Zhao, Xia You, Junze Liu, Xiangrui Guo, Tingting Xie, Jiajie Feng, Fan Zhou, Rui Li, Zhiping Xie, Yanhong Xue, Chuanhai Fu, Yongheng Liang
Publikováno v:
PLoS Genetics, Vol 18, Iss 10, p e1010431 (2022)
It is widely stated in the literature that closed mature autophagosomes (APs) fuse with lysosomes/vacuoles during macroautophagy/autophagy. Previously, we showed that unclosed APs accumulated as clusters outside vacuoles in Vps21/Rab5 and ESCRT mutan
Externí odkaz:
https://doaj.org/article/d707e6ffe54743749a3a5c1256b9ce4b
Autor:
Yin Guan, Yutong Wang, Hongxia Li, Jing Meng, Xia You, Xiaofeng Zhu, Qin Zhang, Tingting Sun, Chuang Qi, Guangyu An, Ying Fan, Binghe Xu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ERBB2 amplification is one of the most important and mature targets for HER2-targeted drug therapy. Somatic mutations of ERBB2 in the tyrosine kinase domain have been studied extensively, and play a role in response to anti-HER2 therapy among differe
Externí odkaz:
https://doaj.org/article/eabcbd28228240d5bac82fe6290de673
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Dermatofibrosarcoma protuberans (DFSP) is a kind of soft tissue sarcoma, mostly occurs in the trunk, followed by proximal extremities and head and neck. Surgical resection is the most important treatment for DFSP, but the local recurrence rate of DFS
Externí odkaz:
https://doaj.org/article/6150d5a7ca664af8979ba4636d52feea
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
More than half of new cases of hepatocellular carcinoma (HCC) and associated deaths occurring annually worldwide are recorded in China. Chinese patients with HCC exhibit special characteristics in terms of etiology, leading to differences in prognosi
Externí odkaz:
https://doaj.org/article/ab6621ed8a654778ae9f1a24e4c84356
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
We presented a 67-year-old nonsmoking female lung adenocarcinoma patient with novel epidermal growth factor receptor (EGFR) A289G/F287_G288insHA cis mutations who responded positively to sintilimab combined with regorafenib and albumin paclitaxel, an
Externí odkaz:
https://doaj.org/article/f1171a91e14c41ffb02171869e7bbd98
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 9, Pp n/a-n/a (2020)
Abstract Background We describe the clinical features, genetic profile, and their correlation in NSCLC patients. Methods A total of 256 Chinese patients with NSCLC were enrolled in this study. NGS‐based genomic profiling of major lung cancer‐rela
Externí odkaz:
https://doaj.org/article/cef1d75ff87742b289337efc64d8f098